Skip to Content

Sino Biopharmaceutical Ltd 01177 Stock Quote

| Rating as of

XHKG: 01177

Last close prices updated as of Feb 09, 2023, 2:03 PM HKT | HKD
  • Last Close 4.54
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Large Value
  • Day Range 4.52  –  4.62
  • Year Range 3.59  –  5.65
  • Market Cap 85.9794 Bil
  • Volume / Avg 12.9 Mil /  45.9 Mil
  • Price / Sales 2.73
  • Price / Book 2.45
  • Forward Div Yield 2.64%
  • Trailing Div Yield 1.31%

Morningstar‘s Stock Analysis 01177

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Sino Biopharmaceutical Has Strong Sales Footprint, but Pipeline Needs More Differentiation

Jay Lee Senior Equity Analyst

Business Strategy and Outlook

| Jay Lee |

Sino Biopharmaceutical, or SBP, is one of the four "Big Pharma" drugmakers in China, and operates in a fast-growing and rapidly changing environment. Drug manufacturing is growing faster than GDP, and we project it to grow at high single digits over the next decade. Additionally, the industry is undergoing massive regulatory change. The most impactful policy is centralized procurement, which is drastically cutting prices for commonly used chemical generics and has hurt SBP's growth.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics 01177

Company Profile 01177

Business Description

Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP’s current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai
Hong Kong, HKG
Industry Biotechnology
Employees 25,552

Related Articles 01177

FAQs for Sino Biopharmaceutical Ltd Stock

Yes. 01177 has a forward dividend yield of 2.64%. See 01177’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

01177’s market cap is 85.98 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

01177’s stock style is Large Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

01177’s price/sales is 2.72.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

01177’s price/forward earnings is 19.76.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

01177’s price/book is 2.45.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See 01177’s valuation ratios compared to the Market Index.

01177’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare 01177’s historical performance against its industry peers and the overall market.